Table 1 Salivary anti-Pnc PS IgG antibodies in the PncOMPC, PncOMPC+PncPS booster and control groups; number and the proportion of positive samples at the age of 7 and 13 months.
Pnc serotype | Age | IgG | |||
|---|---|---|---|---|---|
PncOMPC group | Control group | ||||
N, samples | Number positive (%) | N, samples | Number positive (%) | ||
6B | 7 mo | 56 | 1 (2) | 55 | 0 |
13 mo (PncOMPC booster) | 44 | 3 (7) | 55 | 0 | |
13 mo (PncPS booster) | 6 | 1 (17) | NA | ||
14 | 7 mo | 56 | 2 (4) | 55 | 2 (4) |
13 mo (PncOMPC booster) | 44 | 6 (14)a | 55 | 1 (2) | |
13 mo (PncPS booster) | 6 | 3 (50) | NA | ||
19F | 7 mo | 56 | 2 (4) | 54 | 5 (9) |
13 mo (PncOMPC booster) | 44 | 6 (14) | 55 | 2 (4) | |
13 mo (PncPS booster) | 5 | 3 (60) | NA | ||
23F | 7 mo | 56 | 1 (2) | 54 | 1 (2) |
13 mo (PncOMPC booster) | 44 | 0 | 55 | 1 (2) | |
13 mo (PncPS booster) | 6 | 0 | NA | ||